T38.992
Poisoning by other hormone antagonists, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by other hormone antagonists refers to the harmful effects caused by the ingestion, exposure, or misuse of medications that block or interfere with hormone activity. Under the ICD-10 code T38.992, this condition specifically involves cases where such poisoning is intentionally self-inflicted, often associated with self-harm or suicidal intent. These medications include drugs used to treat hormone-related conditions, such as certain cancer therapies, endocrine disorders, or hormonal treatments. Recognizing and understanding this condition is crucial for prompt medical care and mental health support.
Causes & Symptoms
Clinical Causes: Intentional self-harm or suicide attempts involving hormone antagonists Misuse or overdose of hormone-blocking medications Psychological factors leading to deliberate poisoning Accidental ingestion in individuals with mental health challenges or cognitive impairments
Key Symptoms: Nausea and vomiting Dizziness or lightheadedness Weakness or fatigue Hormonal imbalance symptoms such as irregular menstrual periods or changes in mood Significant drops or elevations in hormone levels, if monitored Possible signs related to specific medications, such as skin reactions or gastrointestinal issues
Diagnostic & Treatment
Diagnosis Path: Diagnosing poisoning by hormone antagonists involves a combination of medical history review, physical examination, and laboratory tests. Blood and urine tests can detect the presence of specific medications or their metabolites. Toxicology screens may identify the exact substance involved. Healthcare providers also assess mental health history and behavioral patterns to ascertain the intent behind the poisoning, particularly when deliberate self-harm is suspected. Imaging or other diagnostic tools might be used if complications or associated injuries are present.
Treatment Protocols: Treatment focuses on stabilizing the patient's condition and preventing further harm. Immediate steps include airway management, decontamination, and supportive care such as intravenous fluids and medication to address symptoms. In cases of intentional self-harm, mental health evaluation and intervention are essential components of care. Additional treatments may involve the use of antidotes or specific therapies for the medication involved, along with monitoring hormonal levels to manage imbalances. Collaboration among healthcare providers, mental health professionals, and social services aims to prevent recurrence and support recovery.
Clinical Advice & FAQs
Billing Guidance
Is T38.992 a billable ICD-10 code?
Yes, T38.992 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T38.992?
Clinical documentation must specify the nature of Poisoning by other hormone antagonists, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference